Effects of exercise on treatment-related adverse effects in breast cancer patients receiving adjuvant hormonal therapy.
Not Applicable
Not yet recruiting
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000052008
- Lead Sponsor
- ational Institute of Fitness and Sports in KANOYA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who is: 1. prohibited from exercise by a physician 2. with severe lymphedema 3. with bone metastatic disease 4. with osteoporosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cancer-related fatigue score (EORTC QLQ-FA12)
- Secondary Outcome Measures
Name Time Method QOL assessment, physical fitness, body composition, bone mineral density
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie exercise-induced mitigation of aromatase inhibitor side effects in breast cancer patients?
How does home-based exercise compare to standard care in managing joint pain and fatigue in postmenopausal breast cancer survivors on hormonal therapy?
Are there specific biomarkers that predict enhanced response to exercise interventions in Japanese breast cancer patients undergoing adjuvant hormonal therapy?
What adverse events are commonly reported in breast cancer trials using home-based exercise programs alongside endocrine therapy, and how are they managed?
How do combination approaches of exercise and pharmacological agents like tamoxifen or letrozole influence outcomes in hormone receptor-positive breast cancer patients?